In vivo monitoring of tumor angiogenesis with MR imaging

Academic Radiology

Volumn 7, Issue 10, 2000, Pages 812-823

  Brasch, Robert ^a   Li, King ^b   Husband, Janet ^c   Keogan, Mary ^d   Neeman, Michal ^e   Padhani, Anwar ^c   Shames, David ^a   Turetschek, Karl ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE ALBUMIN; MONOCLONAL ANTIBODY LM 609; RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL STUDY; CONTRAST ENHANCEMENT; HUMAN; IMMUNOHISTOLOGY; MODEL; MONITORING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TECHNIQUE; TUMOR VASCULARIZATION; VALIDATION PROCESS;

EID: 0033770605     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(00)80630-3     Document Type: Article

References (88)

1. Use of spin echoes in a pulsed magnetic-field gradient to study anisotropic, restricted diffusion and flow
2. Intravoxel incoherent motion imaging using spin echoes
3. Diffusion co-efficients in abdominal organs and hepatic lesions: Evaluation with intravoxel incoherent motion echo-planar MR imaging
4. Perfusion imaging
5. Tissue specific perfusion imaging using arterial spin labeling
6. MR perfusion studies with T1-weighted echo planar imaging
7. Spatial and temporal modulation of perfusion in the rat ovary measured by arterial spin labeling MRI
8. Perfusion of the rat ovary: Application of pulsed arterial spin labeling MRI
9. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields
10. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging: A comparison of signal characteristics with a biophysical model
11. On the characteristics of functional magnetic resonance imaging of the brain
12. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging
13. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging
14. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging
15. Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
16. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging
17. In vivo prediction of vascular susceptibility to endothelial growth factor withdrawal: Magnetic resonance imaging of C6 rat glioma in nude mice
18. Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice
19. The antiangiogenic agent linomide inhibits the growth rate of yon Hippel-Lindau paraganglioma xenografts to mice
20. Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis
21. MR imaging of tumor microcirculation: Promise for the new millennium
22. An exciting and challenging role for the advanced contrast MR imaging
23. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique
24. Staging urinary bladder cancer after transurethral biopsy: Value of fast dynamic contrast-enhanced MR imaging
25. Benign and malignant musculoskeletal lesions: Dynamic contrast-enhanced MR imaging - Parametric 'first-pass' images depict tissue vascularization and perfusion
26. Dynamic contrast enhanced MRI of prostate cancer: Correlation with morphology and tumour stage, histological grade and PSA
27. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography
28. Uterine cervical carcinoma: Comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival
29. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions
30. Angiogenesis of uterine cervical carcinoma: Characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement
31. Angiogenic activity of cervical carcinoma: Assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome
32. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation
33. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI
34. Dynamic echo-planar imaging of the breast: Experience in diagnosing breast carcinoma and correlation with tumor angiogenesis
35. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media
36. Quantitative gadopentetate-enhanced MR imaging of breast tumors: Testing of different analytic methods
37. Pathophysiologic basis of contrast enhancement in breast tumors
38. Cervical carcinoma: Standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival
39. Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis
40. Gd-enhanced dynamic magnetic resonance imaging of breast masses
41. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations
42. Key factors in the acquisition of contrast kinetic data for oncology
43. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI
44. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography
45. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
46. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: Standardized quantities and symbols
47. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
48. Response of MCF7 human breast cancer to tamoxifen: Evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method
49. MRIW: Parametric analysis software for contrast-enhanced dynamic MR imaging in cancer
50. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography
51. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics
52. Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo
53. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot
54. A rapid interleaved method for measuring signal intensity curves in both blood and tissue during contrast agent administration
55. Microvascular permeability of normal and neoplastic tissues
56. Barriers to drug delivery in solid tumors
57. Transport of molecules across tumor vasculature
58. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density
59. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
60. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization
61. Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha
62. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique
63. Optimizing imaging techniques to reduce errors in microvascular quantitation with macromolecular MR contrast agents
64. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor
65. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries
66. False-positive cases in dynamic MR mammography
67. Identification and characterization of the blood vessels of solid tumors that are leaky to circularing macromolecules
68. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
69. Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model
70. Quantitation and physiological characterization of angiogenic vessels in mice: Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment
71. Quantitative angiogenesis assays: Progress and problems
72. Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis
73. Microvascular density in terms of number and length of microvessel segments per unit tissue volume in mammalian angiogenesis
74. Tumor angiogenesis: A quantitative method for histologic grading
75. Markers of tumor angiogenesis: Clinical applications in prognosis and anti-angiogenic therapy
76. Vascular density in human melanoma xenografts: Relationship to angiogenesis, perfusion and necrosis
77. Paramagnetic polymerized liposomes as new recirculating MR contrast agents
78. Paramagnetic polymerized liposomes: Synthesis, characterization, and applications for magnetic resonance imaging
79. Requirement of vascular integrin alpha v beta 3 for angiogenesis
80. Integrin vβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
81. The role of v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
82. Detection of tumor angiogenesis in vivo by Vβ3-targeted magnetic resonance imaging
83. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: A possible marker of vascular tortuosity
84. NMR imaging of changes in vascular morphology due to tumor angiogenesis
85. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies